STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Clinical trials for STAGE III PRIMARY PERITONEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PRIMARY PERITONEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PRIMARY PERITONEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets BRCA cancers in early trial
Disease control OngoingThis early-phase trial tests a combination of two drugs—niraparib (a PARP inhibitor) and dostarlimab (an immunotherapy)—in people with BRCA-mutated breast, pancreas, or ovarian cancers that have spread or cannot be surgically removed. The goal is to see if the combo can shrink tu…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
New drug shows promise in shrinking ovarian tumors before surgery
Disease control OngoingThis early-phase trial is testing the drug olaparib in 15 people with newly diagnosed BRCA-mutant ovarian, fallopian tube, or peritoneal cancer before they have surgery. The goal is to see if taking olaparib for two cycles can safely shrink tumors and stop them from growing. Olap…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can a simple hormone pill replace chemo for some ovarian cancers?
Disease control OngoingThis study tests whether the hormone therapy letrozole alone works as well as chemotherapy plus letrozole for people with stage II to IV low-grade serous ovarian, fallopian tube, or peritoneal cancer. Letrozole lowers estrogen, which can slow tumor growth. The trial aims to find …
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New drug combo shows promise in ovarian cancer safety trial
Disease control OngoingThis early-phase study tested adding the experimental drug ipatasertib to standard chemotherapy (paclitaxel and carboplatin) for people with stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The main goals were to find the safest dose and check for side effec…
Matched conditions: STAGE III PRIMARY PERITONEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:39 UTC